Amprius Technologies, Inc. (NYSE: AMPX), a leading provider of advanced lithium-ion battery technology, was assumed by EF Hutton with a Buy rating and a price target of $14.

With $AMPX closing at $6.98 on Monday, the assigned price target suggests a potential upside of $7.02 or approximately 100.43% based on the brokerage firm's analysis.

Rivian Automotive, Inc. (Nasdaq: RIVN), a prominent electric vehicle manufacturer, was maintained with a Buy rating by Needham, who raised the price target from $26 to $28.

Despite closing at $19.56 on Monday, the adjusted price target indicates a potential upside of $8.44 or about 43.14% for $RIVN, according to Needham's assessment.

4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage biopharmaceutical company focused on gene therapy, received coverage initiation from Chardan Capital with a Buy rating and a price target of $30.

Based on Monday's closing price of $17.86, the assigned price target implies a potential upside of $12.14 or approximately 68.06% for $FDMT, according to the investment firm's view.

CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a pharmaceutical company specializing in liver and metabolic diseases, was maintained with a Buy rating by BTIG, who raised the price target from $15 to $18.

Despite $CBAY closing at $11.70 on Monday, the adjusted price target suggests a potential upside of $6.30 or about 53.85%, based on the financial services firm's assessment.

Hertz Global Holdings, Inc. (Nasdaq: HTZ), a leading car rental company, received coverage initiation by Jefferies with a Buy rating and a price target of $24.

With $HTZ closing at $18.45 on Monday, the assigned price target implies a potential upside of $5.55 or approximately 30.08% according to the investment advisory firm's analysis.

PEDEVCO Corp. (NYSE American: PED), an energy company engaged in the exploration and production of oil and gas, was assumed by EF Hutton with a Buy rating and a price target of $2.4.

Based on Monday's closing price of $0.91, the assigned price target suggests a potential upside of $1.49 or about 163.74% for $PED, according to the investment firm's view.

It is important to note that the potential upsides mentioned for these companies are derived from the assessments and recommendations of the respective brokerage/investment firms, reflecting their outlook on the future performance of each company. However, it is strongly advised that investors conduct their own thorough research and take into account various factors before making any investment decisions.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)